Alexey Popov

Alexey Popov is an accomplished leader in pharmaceutical development with extensive experience in process development for innovative drug delivery systems. Currently serving as Vice President of Process Development at Sail Biomedicines, which emerged from the merger of Senda Biosciences and Laronde, Alexey is responsible for advancing proprietary nanoparticle components into GMP manufacturing. Previous roles include Vice President of Process Development at Senda Biosciences, where Alexey led the company's IND Readiness strategy and CMC workstreams, and Vice President at Kala Pharmaceuticals, contributing to the company's growth from its inception to a publicly traded entity with two FDA-approved products. Alexey's career also includes significant positions at Johnson & Johnson and SLB, complemented by academic credentials of a Ph.D. and M.S. in Polymer Science & Engineering from the University of Massachusetts Amherst, and a diploma in Chemistry from Lomonosov Moscow State University.